Two Sigma Advisers’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-76,000
| Closed | -$60.8K | – | 2445 |
|
2025
Q1 | $60.8K | Buy |
+76,000
| New | +$60.8K | ﹤0.01% | 2305 |
|
2023
Q3 | – | Sell |
-25,700
| Closed | -$73.2K | – | 2499 |
|
2023
Q2 | $73.2K | Buy |
25,700
+11,400
| +80% | +$32.5K | ﹤0.01% | 2240 |
|
2023
Q1 | $56.3K | Sell |
14,300
-34,800
| -71% | -$137K | ﹤0.01% | 2439 |
|
2022
Q4 | $194K | Buy |
+49,100
| New | +$194K | ﹤0.01% | 2198 |
|
2021
Q3 | – | Sell |
-35,600
| Closed | -$196K | – | 2587 |
|
2021
Q2 | $196K | Sell |
35,600
-22,500
| -39% | -$124K | ﹤0.01% | 2274 |
|
2021
Q1 | $336K | Buy |
58,100
+5,800
| +11% | +$33.5K | ﹤0.01% | 2181 |
|
2020
Q4 | $350K | Buy |
+52,300
| New | +$350K | ﹤0.01% | 1993 |
|
2020
Q3 | – | Sell |
-20,900
| Closed | -$79K | – | 2554 |
|
2020
Q2 | $79K | Buy |
+20,900
| New | +$79K | ﹤0.01% | 2390 |
|